Vicore Pharma Holding AB Pareto Interview Transcript
Hello, everyone. It's my pleasure to have the Vicore CEO today with us, and we are going to go to some of the recent news flow the company had and also that the field of IPF had.
Questions & Answers
So, Carl-Johan, so just recently presented the quite compelling data in Raynaud's phenomena. Could you explain why you think the data was good there?
Yeah. I mean, this was a small experimental study where we wanted to answer one question. And the question was: can we dilate the small vessels in the fibrotic tissue? And the answer was yes. And we showed that in the measure from zero to 15 minutes.
And we were very happy with these results because it means that we now have a second clinical validation of the angiotensin type 2 target and the first one then being the positive data in the COVID trial. So I think we're now starting to believe that this is
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
